Life and cancer without telomerase: ALT and other strategies for making sure ends (don’t) meet

Critical Reviews in Biochemistry and Molecular Biology

Volumn 52, Issue 1, 2017, Pages 57-73

  Apte, Manasi S ^a   Cooper, Julia Promisel ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ALT; chromatin; DNA damage response; genome stability; HAATI; heterochromatin; recombination; telomerase; Telomere

Indexed keywords

LONG UNTRANSLATED RNA; RNA; TELOMERASE; TELOMERIC REPEAT CONTAINING RNA; UNCLASSIFIED DRUG; CHROMATIN; HETEROCHROMATIN;

ALTERNATIVE LENGTHENING OF TELOMERE; ASTROCYTOMA; BREAST CARCINOMA; BUDDING YEAST; CANCER CELL; CANCER THERAPY; CHROMATIN; CHROMOSOMAL INSTABILITY; CHROMOSOME REPLICATION; DIPTERA; DNA REPAIR; FISSION YEAST; GLIOBLASTOMA; HOMOLOGOUS RECOMBINATION; LIPOSARCOMA; MALIGNANT NEOPLASM; MOLECULAR EVOLUTION; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; REVIEW; TELOMERE; TELOMERE HOMEOSTASIS; ANIMAL; DNA DAMAGE; GENETIC TRANSCRIPTION; GENETICS; GENOMIC INSTABILITY; HETEROCHROMATIN; HUMAN; METABOLISM; NEOPLASMS;

ANIMALS; CHROMATIN; DNA DAMAGE; DNA REPAIR; EVOLUTION, MOLECULAR; GENOMIC INSTABILITY; HETEROCHROMATIN; HOMOLOGOUS RECOMBINATION; HUMANS; NEOPLASMS; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS; TRANSCRIPTION, GENETIC;

EID: 85009461036     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.1080/10409238.2016.1260090     Document Type: Review

References (168)

1. Aguilera A, Garcia-Muse T., (2012). R loops:from transcription byproducts to threats to genome stability. Mol Cell 46:115–24.
2. Almeida H, Godinho Ferreira M., (2013). Spontaneous telomere to telomere fusions occur in unperturbed fission yeast cells. Nucleic Acids Res 41:3056–67.
3. Armstrong L, Lako M, Lincoln J, et al. (2000). mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells. Mech Dev 97:109–16.
4. Arora R, Lee Y, Wischnewski H, et al. (2014). RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells. Nat Commun 5:5220.
5. Atkinson SP, Hoare SF, Glasspool RM, Keith WN., (2005). Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res 65:7585–90.
6. Azzalin CM, Lingner J., (2015). Telomere functions grounding on TERRA firma. Trends Cell Biol 25:29–36.
7. Azzalin CM, Reichenbach P, Khoriauli L, et al. (2007). Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318:798–801.
8. Bah A, Wischnewski H, Shchepachev V, Azzalin CM., (2012). The telomeric transcriptome of Schizosaccharomyces pombe. Nucleic Acids Res 40:2995–3005.
9. Bailey SM, Brenneman MA, Goodwin EH., (2004). Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res 32:3743–51.
10. Balk B, Maicher A, Dees M, et al. (2013). Telomeric RNA-DNA hybrids affect telomere-length dynamics and senescence. Nat Struct Mol Biol 20:1199–205.
11. Bansbach CE, Betous R, Lovejoy CA, et al. (2009). The annealing helicase SMARCAL1 maintains genome integrity at stalled replication forks. Genes Dev 23:2405–14.
12. Barber LJ, Youds JL, Ward JD, et al. (2008). RTEL1 maintains genomic stability by suppressing homologous recombination. Cell 135:261–71.
13. Beernink HT, Miller K, Deshpande A, et al. (2003). Telomere maintenance in fission yeast requires an Est1 ortholog. Curr Biol 13:575–80.
14. Benetti R, Garcia-Cao M, Blasco MA., (2007). Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet 39:243–50.
15. Benetti R, Schoeftner S, Munoz P, Blasco MA., (2008). Role of TRF2 in the assembly of telomeric chromatin. Cell Cycle 7:3461–8.
16. Bhattacharyya S, Keirsey J, Russell B, et al. (2009). Telomerase-associated protein 1, HSP90, and topoisomerase IIalpha associate directly with the BLM helicase in immortalized cells using ALT and modulate its helicase activity using telomeric DNA substrates. J Biol Chem 284:14966–77.
17. Bisht KK, Daniloski Z, Smith S., (2013). SA1 binds directly to DNA through its unique AT-hook to promote sister chromatid cohesion at telomeres. J Cell Sci 126:3493–503.
18. Blasco MA., (2007). The epigenetic regulation of mammalian telomeres. Nat Rev Genet 8:299–309.
19. Boule JB, Zakian VA., (2007). The yeast Pif1p DNA helicase preferentially unwinds RNA DNA substrates. Nucleic Acids Res 35:5809–18.
20. Bourc'his D, Xu GL, Lin CS, et al. (2001). Dnmt3L and the establishment of maternal genomic imprints. Science 294:2536–9.
21. Bryan TM, Englezou A, Dalla-Pozza L, et al. (1997). Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3:1271–4.
22. Capkova Frydrychova R, Biessmann H, Mason JM., (2008). Regulation of telomere length in Drosophila. Cytogenet Genome Res 122:356–64.
23. Cenci G, Ciapponi L, Gatti M., (2005). The mechanism of telomere protection:a comparison between Drosophila and humans. Chromosoma 114:135–45.
24. Cenci G, Ciapponi L, Marzullo M, et al. (2015). The analysis of pendolino (peo) mutants reveals differences in the fusigenic potential among drosophila telomeres. PLoS Genet 11:e1005260.
25. Cenci G, Siriaco G, Raffa GD, et al. (2003). The Drosophila HOAP protein is required for telomere capping. Nat Cell Biol 5:82–4.
26. Cerone MA, Londono-Vallejo JA, Bacchetti S., (2001). Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum Mol Genet 10:1945–52.
27. Cesare AJ, Griffith JD., (2004). Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol Cell Biol 24:9948–57.
28. Cesare AJ, Reddel RR., (2010). Alternative lengthening of telomeres:models, mechanisms and implications. Nat Rev Genet 11:319–30.
29. Chawla R, Redon S, Raftopoulou C, et al. (2011). Human UPF1 interacts with TPP1 and telomerase and sustains telomere leading-strand replication. EMBO J 30:4047–58.
30. Chen B, Gilbert LA, Cimini BA, et al. (2013). Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155:1479–91.
31. Cho NW, Dilley RL, Lampson MA, Greenberg RA., (2014). Interchromosomal homology searches drive directional ALT telomere movement and synapsis. Cell 159:108–21.
32. Ciapponi L, Cenci G., (2008). Telomere capping and cellular checkpoints:clues from fruit flies. Cytogenet Genome Res 122:365–73.
33. Ciccia A, Bredemeyer AL, Sowa ME, et al. (2009). The SIOD disorder protein SMARCAL1 is an RPA-interacting protein involved in replication fork restart. Genes Dev 23:2415–25.
34. Clynes D, Higgs DR, Gibbons RJ., (2013). The chromatin remodeller ATRX:a repeat offender in human disease. Trends Biochem Sci 38:461–6.
35. Conomos D, Stutz MD, Hills M, et al. (2012). Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells. J Cell Biol 199:893–906.
36. Cooper JP, Nimmo ER, Allshire RC, Cech TR., (1997). Regulation of telomere length and function by a Myb-domain protein in fission yeast. Nature 385:744–7.
37. Costa A, Daidone MG, Daprai L, et al. (2006). Telomere maintenance mechanisms in liposarcomas:association with histologic subtypes and disease progression. Cancer Res 66:8918–24.
38. Cox KE, Marechal A, Flynn RL., (2016). SMARCAL1 resolves replication stress at ALT telomeres. Cell Rep 14:1032–40.
39. Cusanelli E, Chartrand P., (2015). Telomeric repeat-containing RNA TERRA:a noncoding RNA connecting telomere biology to genome integrity. Front Genet 6:143.
40. Cusanelli E, Romero CA, Chartrand P., (2013). Telomeric noncoding RNA TERRA is induced by telomere shortening to nucleate telomerase molecules at short telomeres. Mol Cell 51:780–91.
41. Dawson SJ, Rueda OM, Aparicio S, Caldas C., (2013). A new genome-driven integrated classification of breast cancer and its implications. EMBO J 32:617–28.
42. De Lange T., (2005). Shelterin:the protein complex that shapes and safeguards human telomeres. Genes Dev 19:2100–10.
43. Dejardin J, Kingston RE., (2009). Purification of proteins associated with specific genomic Loci. Cell 136:175–86.
44. Deng Z, Norseen J, Wiedmer A, et al. (2009). TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol Cell 35:403–13.
45. Diede SJ, Gottschling DE., (1999). Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases alpha and delta. Cell 99:723–33.
46. Dimitrova N, Chen YC, Spector DL, De Lange T., (2008). 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. Nature 456:524–8.
47. Ding H, Schertzer M, Wu X, et al. (2004). Regulation of murine telomere length by Rtel:an essential gene encoding a helicase-like protein. Cell 117:873–86.
48. Dion V, Kalck V, Horigome C, et al. (2012). Increased mobility of double-strand breaks requires Mec1, Rad9 and the homologous recombination machinery. Nat Cell Biol 14:502–9.
49. Doksani Y, Wu JY, De Lange T, Zhuang X., (2013). Super-resolution fluorescence imaging of telomeres reveals TRF2-dependent T-loop formation. Cell 155:345–56.
50. Dynek JN, Smith S., (2004). Resolution of sister telomere association is required for progression through mitosis. Science 304:97–100.
51. Elsasser SJ, Huang H, Lewis PW, et al. (2012). DAXX envelops a histone H3.3-H4 dimer for H3.3-specific recognition. Nature 491:560–5.
52. Episkopou H, Draskovic I, Van Beneden A, et al. (2014). Alternative lengthening of telomeres is characterized by reduced compaction of telomeric chromatin. Nucleic Acids Res 42:4391–405.
53. Fanti L, Giovinazzo G, Berloco M, Pimpinelli S., (1998). The heterochromatin protein 1 prevents telomere fusions in Drosophila. Mol Cell 2:527–38.
54. Flynn RL, Cox KE, Jeitany M, et al. (2015). Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors. Science 347:273–7.
55. Foote KM, Blades K, Cronin A, et al. (2013). Discovery of 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20):a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity. J Med Chem 56:2125–38.
56. Galati A, Magdinier F, Colasanti V, et al. (2012). TRF2 controls telomeric nucleosome organization in a cell cycle phase-dependent manner. PLoS One 7:e34386.
57. Galati A, Micheli E, Alicata C, et al. (2015). TRF1 and TRF2 binding to telomeres is modulated by nucleosomal organization. Nucleic Acids Res 43:5824–37.
58. Gao G, Walser JC, Beaucher ML, et al. (2010). HipHop interacts with HOAP and HP1 to protect Drosophila telomeres in a sequence-independent manner. EMBO J 29:819–29.
59. Garcia-Cao M, O'sullivan R, Peters AH, et al. (2004). Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet 36:94–9.
60. Goldberg AD, Banaszynski LA, Noh KM, et al. (2010). Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140:678–91.
61. Gonzalo S, Jaco I, Fraga MF, et al. (2006). DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8:416–24.
62. Gottschling DE, Aparicio OM, Billington BL, Zakian VA., (1990). Position effect at S. cerevisiae telomeres:reversible repression of Pol II transcription. Cell 63:751–62.
63. Greenwood J, Cooper JP., (2012). Non-coding telomeric and subtelomeric transcripts are differentially regulated by telomeric and heterochromatin assembly factors in fission yeast. Nucleic Acids Res 40:2956–63.
64. Grewal SI, Jia S., (2007). Heterochromatin revisited. Nat Rev Genet 8:35–46.
65. Griffith JD, Comeau L, Rosenfield S, et al. (1999). Mammalian telomeres end in a large duplex loop. Cell 97:503–14.
66. Hakin-Smith V, Jellinek DA, Levy D, et al. (2003). Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 361:836–8.
67. Heaphy CM, De Wilde RF, Jiao Y, et al. (2011a). Altered telomeres in tumors with ATRX and DAXX mutations. Science 333:425.
68. Heaphy CM, Subhawong AP, Hong SM, et al. (2011b). Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 179:1608–15.
69. Hensen EF, Goeman JJ, Oosting J, et al. (2009). Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesis. BMC Med Genomics 2:25.
70. Henson JD, Reddel RR., (2010). Assaying and investigating alternative lengthening of telomeres activity in human cells and cancers. FEBS Lett 584:3800–11.
71. Hu J, Hwang SS, Liesa M, et al. (2012). Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell 148:651–63.
72. Jain D, Cooper JP., (2010). Telomeric strategies:means to an end. Annu Rev Genet 44:243–69.
73. Jain D, Hebden AK, Nakamura TM, et al. (2010). HAATI survivors replace canonical telomeres with blocks of generic heterochromatin. Nature 467:223–7.
74. Jeyapalan JN, Mendez-Bermudez A, Zaffaroni N, et al. (2008). Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies. Int J Cancer 122:2414–21.
75. Josse R, Martin SE, Guha R, et al. (2014). ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses. Cancer Res 74:6968–79.
76. Jung AR, Yoo JE, Shim YH, et al. (2013). Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin–a treatment. Anticancer Res 33:821–9.
77. Kanoh J, Sadaie M, Urano T, Ishikawa F., (2005). Telomere binding protein Taz1 establishes Swi6 heterochromatin independently of RNAi at telomeres. Curr Biol 15:1808–19.
78. Karlseder J, Broccoli D, Dai Y, et al. (1999). p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283:1321–5.
79. Khurana JS, Xu J, Weng Z, Theurkauf WE., (2010). Distinct functions for the Drosophila piRNA pathway in genome maintenance and telomere protection. PLoS Genet 6:e1001246.
80. Kim KT, Lee HW, Lee HO, et al. (2015). Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells. Genome Biol 16:127.
81. Lafferty-Whyte K, Cairney CJ, Will MB, et al. (2009). A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. Oncogene 28:3765–74.
82. Larrivee M, Wellinger RJ., (2006). Telomerase- and capping-independent yeast survivors with alternate telomere states. Nat Cell Biol 8:741–7.
83. Law MJ, Lower KM, Voon HP, et al. (2010). ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell 143:367–78.
84. Lee M, Hills M, Conomos D, et al. (2014). Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processes. Nucleic Acids Res 42:1733–46.
85. Lewis PW, Elsaesser SJ, Noh KM, et al. (2010). Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci USA 107:14075–80.
86. Lingner J, Cooper JP, Cech TR., (1995). Telomerase and DNA end replication:no longer a lagging strand problem? Science 269:1533–4.
87. Londono-Vallejo JA, Der-Sarkissian H, Cazes L, et al. (2004). Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res 64:2324–7.
88. Louis EJ, Haber JE., (1990). Mitotic recombination among subtelomeric Y' repeats in Saccharomyces cerevisiae. Genetics 124:547–59.
89. Louis EJ, Haber JE., (1992). The structure and evolution of subtelomeric Y' repeats in Saccharomyces cerevisiae. Genetics 131:559–74.
90. Lovejoy CA, Li W, Reisenweber S, et al. (2012). Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet 8:e1002772.
91. Loyola A, Bonaldi T, Roche D, et al. (2006). PTMs on H3 variants before chromatin assembly potentiate their final epigenetic state. Mol Cell 24:309–16.
92. Lundblad V, Blackburn EH., (1993). An alternative pathway for yeast telomere maintenance rescues est1- senescence. Cell 73:347–60.
93. Lundblad V, Szostak JW., (1989). A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57:633–43.
94. Lydeard JR, Jain S, Yamaguchi M, Haber JE., (2007). Break-induced replication and telomerase-independent telomere maintenance require Pol32. Nature 448:820–3.
95. Makarov VL, Lejnine S, Bedoyan J, Langmore JP., (1993). Nucleosomal organization of telomere-specific chromatin in rat. Cell 73:775–87.
96. Maringele L, Lydall D., (2004). EXO1 plays a role in generating type I and type II survivors in budding yeast. Genetics 166:1641–9.
97. Maringele L, Lydall D., (2005). The PAL-mechanism of chromosome maintenance:causes and consequences. Cell Cycle 4:747–51.
98. Melnikova L, Biessmann H, Georgiev P., (2005). The Ku protein complex is involved in length regulation of Drosophila telomeres. Genetics 170:221–35.
99. Miller KM, Jackson SP., (2012). Histone marks:repairing DNA breaks within the context of chromatin. Biochem Soc Trans 40:370–6.
100. Miller KM, Rog O, Cooper JP., (2006). Semi-conservative DNA replication through telomeres requires Taz1. Nature 440:824–8.
101. Morgunova V, Akulenko N, Radion E, et al. (2015). Telomeric repeat silencing in germ cells is essential for early development in Drosophila. Nucleic Acids Res 43:8762–73.
102. Muntoni A, Neumann AA, Hills M, Reddel RR., (2009). Telomere elongation involves intra-molecular DNA replication in cells utilizing alternative lengthening of telomeres. Hum Mol Genet 18:1017–27.
103. Murnane JP, Sabatier L, Marder BA, Morgan WF., (1994). Telomere dynamics in an immortal human cell line. EMBO J 13:4953–62.
104. Nakamura TM, Cooper JP, Cech TR., (1998). Two modes of survival of fission yeast without telomerase. Science 282:493–6.
105. Napier CE, Huschtscha LI, Harvey A, et al. (2015). ATRX represses alternative lengthening of telomeres. Oncotarget 6:16543–58.
106. Natarajan S, Mceachern MJ., (2002). Recombinational telomere elongation promoted by DNA circles. Mol Cell Biol 22:4512–21.
107. Neumann AA, Watson CM, Noble JR, et al. (2013). Alternative lengthening of telomeres in normal mammalian somatic cells. Genes Dev 27:18–23.
108. Nikitina T, Woodcock CL., (2004). Closed chromatin loops at the ends of chromosomes. J Cell Biol 166:161–5.
109. Nimmo ER, Cranston G, Allshire RC., (1994). Telomere-associated chromosome breakage in fission yeast results in variegated expression of adjacent genes. EMBO J 13:3801–11.
110. Nittis T, Guittat L, Stewart SA., (2008). Alternative lengthening of telomeres (ALT) and chromatin:is there a connection? Biochimie 90:5–12.
111. O'Sullivan RJ, Arnoult N, Lackner DH, et al. (2014). Rapid induction of alternative lengthening of telomeres by depletion of the histone chaperone ASF1. Nat Struct Mol Biol 21:167–74.
112. Olovnikov AM., (1973). A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 41:181–90.
113. Paeschke K, Bochman ML, Garcia PD, et al. (2013). Pif1 family helicases suppress genome instability at G-quadruplex motifs. Nature 497:458–62.
114. Palladino F, Laroche T, Gilson E, et al. (1993). SIR3 and SIR4 proteins are required for the positioning and integrity of yeast telomeres. Cell 75:543–55.
115. Perrem K, Colgin LM, Neumann AA, et al. (2001). Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol 21:3862–75.
116. Perrini B, Piacentini L, Fanti L, et al. (2004). HP1 controls telomere capping, telomere elongation, and telomere silencing by two different mechanisms in Drosophila. Mol Cell 15:467–76.
117. Pfeiffer V, Crittin J, Grolimund L, Lingner J., (2013). The THO complex component Thp2 counteracts telomeric R-loops and telomere shortening. EMBO J 32:2861–71.
118. Pickett HA, Reddel RR., (2015). Molecular mechanisms of activity and derepression of alternative lengthening of telomeres. Nat Struct Mol Biol 22:875–80.
119. Pisano S, Leoni D, Galati A, et al. (2010). The human telomeric protein hTRF1 induces telomere-specific nucleosome mobility. Nucleic Acids Res 38:2247–55.
120. Poole LA, Zhao R, Glick GG, et al. (2015). SMARCAL1 maintains telomere integrity during DNA replication. Proc Natl Acad Sci USA 112:14864–9.
121. Porro A, Feuerhahn S, Delafontaine J, et al. (2014a). Functional characterization of the TERRA transcriptome at damaged telomeres. Nat Commun 5:5379.
122. Porro A, Feuerhahn S, Lingner J., (2014b). TERRA-reinforced association of LSD1 with MRE11 promotes processing of uncapped telomeres. Cell Rep 6:765–76.
123. Potts PR, Yu H., (2007). The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat Struct Mol Biol 14:581–90.
124. Raffa GD, Cenci G, Ciapponi L, Gatti M., (2013). Organization and maintenance of Drosophila telomeres:the roles of terminin and non-terminin proteins. Tsitologiia 55:204–8.
125. Raffa GD, Ciapponi L, Cenci G, Gatti M., (2011). Terminin:a protein complex that mediates epigenetic maintenance of Drosophila telomeres. Nucleus 2:383–91.
126. Raffa GD, Raimondo D, Sorino C, et al. (2010). Verrocchio, a Drosophila OB fold-containing protein, is a component of the terminin telomere-capping complex. Genes Dev 24:1596–601.
127. Raffa GD, Siriaco G, Cugusi S, et al. (2009). The Drosophila modigliani (moi) gene encodes a HOAP-interacting protein required for telomere protection. Proc Natl Acad Sci USA 106:2271–6.
128. Ramamoorthy M, Smith S., (2015). Loss of ATRX suppresses resolution of telomere cohesion to control recombination in ALT cancer cells. Cancer Cell 28:357–69.
129. Ratnakumar K, Duarte LF, Leroy G, et al. (2012). ATRX-mediated chromatin association of histone variant macroH2A1 regulates alpha-globin expression. Genes Dev 26:433–8.
130. Reichenbach P, Hoss M, Azzalin CM, et al. (2003). A human homolog of yeast Est1 associates with telomerase and uncaps chromosome ends when overexpressed. Curr Biol 13:568–74.
131. Rog O, Miller KM, Ferreira MG, Cooper JP., (2009). Sumoylation of RecQ helicase controls the fate of dysfunctional telomeres. Mol Cell 33:559–69.
132. Rondon AG, Jimeno S, Aguilera A., (2010). The interface between transcription and mRNP export:from THO to THSC/TREX-2. Biochim Biophys Acta 1799:533–8.
133. Rong YS., (2008). Telomere capping in Drosophila:dealing with chromosome ends that most resemble DNA breaks. Chromosoma 117:235–42.
134. Roukos V, Voss TC, Schmidt CK, et al. (2013). Spatial dynamics of chromosome translocations in living cells. Science 341:660–4.
135. Ruden M, Puri N., (2013). Novel anticancer therapeutics targeting telomerase. Cancer Treat Rev 39:444–56.
136. Sarek G, Vannier JB, Panier S, et al. (2015). TRF2 recruits RTEL1 to telomeres in S phase to promote t-loop unwinding. Mol Cell 57:622–35.
137. Schoeftner S, Blasco MA., (2008). Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol 10:228–36.
138. Schwartzentruber J, Korshunov A, Liu XY, et al. (2012). Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226–31.
139. Sfeir A, Kosiyatrakul ST, Hockemeyer D, et al. (2009). Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138:90–103.
140. Sharpless NE, Depinho RA., (2004). Telomeres, stem cells, senescence, and cancer. J Clin Invest 113:160–8.
141. Shay JW, Bacchetti S., (1997). A survey of telomerase activity in human cancer. Eur J Cancer 33:787–91.
142. Silva-Sousa R, Lopez-Panades E, Pineyro D, Casacuberta E., (2012). The chromosomal proteins JIL-1 and Z4/Putzig regulate the telomeric chromatin in Drosophila melanogaster. PLoS Genet 8:e1003153.
143. Slatter T, Gifford-Garner J, Wiles A, et al. (2010). Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeres. Am J Pathol 177:2694–700.
144. Subhawong AP, Heaphy CM, Argani P, et al. (2009). The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression. Mod Pathol 22:1423–31.
145. Subramanian L, Moser BA, Nakamura TM., (2008). Recombination-based telomere maintenance is dependent on Tel1-MRN and Rap1 and inhibited by telomerase, Taz1, and Ku in fission yeast. Mol Cell Biol 28:1443–55.
146. Tabori U, Vukovic B, Zielenska M, et al. (2006). The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas. Neoplasia 8:136–42.
147. Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y., (2004). Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 116:51–61.
148. Temime-Smaali N, Guittat L, Wenner T, et al. (2008). Topoisomerase IIIalpha is required for normal proliferation and telomere stability in alternative lengthening of telomeres. EMBO J 27:1513–24.
149. Teng SC, Zakian VA., (1999). Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae. Mol Cell Biol 19:8083–93.
150. Titen SW, Golic KG., (2010). Healing of euchromatic chromosome breaks by efficient de novo telomere addition in Drosophila melanogaster. Genetics 184:309–12.
151. Tommerup H, Dousmanis A, De Lange T., (1994). Unusual chromatin in human telomeres. Mol Cell Biol 14:5777–85.
152. Torok T, Benitez C, Takacs S, Biessmann H., (2007). The protein encoded by the gene proliferation disrupter (prod) is associated with the telomeric retrotransposon array in Drosophila melanogaster. Chromosoma 116:185–95.
153. Udugama M, Ft MC, Chan FL, et al. (2015). Histone variant H3.3 provides the heterochromatic H3 lysine 9 tri-methylation mark at telomeres. Nucleic Acids Res 43:10227–37.
154. Van Steensel B, De Lange T., (1997). Control of telomere length by the human telomeric protein TRF1. Nature 385:740–3.
155. Van Steensel B, Smogorzewska A, De Lange T., (1998). TRF2 protects human telomeres from end-to-end fusions. Cell 92:401–13.
156. Vannier JB, Pavicic-Kaltenbrunner V, Petalcorin MI, et al. (2012). RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell 149:795–806.
157. Varley H, Pickett HA, Foxon JL, et al. (2002). Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells. Nat Genet 30:301–5.
158. Villa R, Daidone MG, Motta R, et al. (2008). Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. Clin Cancer Res 14:4134–40.
159. Wang N, Xu D, Sofiadis A, et al. (2014). Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma. J Clin Endocrinol Metab 99:E1571–9.
160. Wang X, Baumann P., (2008). Chromosome fusions following telomere loss are mediated by single-strand annealing. Mol Cell 31:463–73.
161. Watson JD., (1972). Origin of concatemeric T7 DNA. Nature New Biol 239:197–201.
162. Watson LA, Solomon LA, Li JR, et al. (2013). Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. J Clin Invest 123:2049–63.
163. Wellinger RJ, Zakian VA., (2012). Everything you ever wanted to know about Saccharomyces cerevisiae telomeres:beginning to end. Genetics 191:1073–105.
164. Whitehouse I, Owen-Hughes T., (2010). ATRX:Put me on repeat. Cell 143:335–6.
165. Williams ES, Cornforth MN, Goodwin EH, Bailey SM., (2011). Co-fish, cod-fish, red-fish, sky-fish. Methods Mol Biol 735:113–24.
166. Xu Y, Goldkorn A., (2016). Telomere and telomerase therapeutics in cancer. Genes (Basel). doi:10.3390/genes7060022.7.
167. Yeager TR, Neumann AA, Englezou A, et al. (1999). Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59:4175–9.
168. Yuan Y, Liu L, Chen H, et al. (2016). Comprehensive characterization of molecular differences in cancer between male and female patients. Cancer Cell 29:711–22.